AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 50 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,830,000 | +23.5% | 232,002 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,100,000 | +134.0% | 232,002 | +15.9% | 0.00% | +100.0% |
| Q2 2016 | $1,325,000 | -24.9% | 200,100 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,765,000 | -12.8% | 200,100 | +23.4% | 0.00% | 0.0% |
| Q4 2015 | $2,024,000 | -11.3% | 162,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,282,000 | +552.0% | 162,200 | +221.8% | 0.00% | – |
| Q2 2015 | $350,000 | -15.5% | 50,400 | 0.0% | 0.00% | – |
| Q1 2015 | $414,000 | +13.1% | 50,400 | +3.3% | 0.00% | – |
| Q4 2014 | $366,000 | +12.6% | 48,800 | 0.0% | 0.00% | – |
| Q3 2014 | $325,000 | -29.3% | 48,800 | 0.0% | 0.00% | – |
| Q2 2014 | $460,000 | -25.9% | 48,800 | 0.0% | 0.00% | – |
| Q1 2014 | $621,000 | – | 48,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |